ArticleHaematologica2024

Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma.

Romane Durand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.